Elevai Labs
ELAB
1 hedge funds and large institutions have $228K invested in Elevai Labs in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
163% more capital invested
Capital invested by funds: $86.9K → $228K (+$141K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$842K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WTC
WhitTier Trust Company
Reno,
Nevada
|
-$46.8K |
| 2 |
VF
Virtu Financial
New York
|
-$6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.62K |
ELAB Hedge Fund Activity: Q3 2024 in Review
1 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Elevai Labs (ELAB) for Q3 2024, worth a combined $228K — up 163% from $86.9K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ELAB positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $842K. The largest seller was WhitTier Trust Company, cutting an estimated $46.8K.
- 1 institutional investor held Elevai Labs (ELAB) as of Q3 2024, up from 0 in Q2 2024.
- Funds reported $228K of Elevai Labs stock for Q3 2024, up 163% quarter-over-quarter.
- 1 fund opened new Elevai Labs positions in Q3 2024 and 0 closed out, a net change of +1 holder.
- The largest Elevai Labs buyer in Q3 2024 was Sabby Management, an estimated $842K added.
- The largest Elevai Labs seller in Q3 2024 was WhitTier Trust Company, an estimated $46.8K sold.
Based on aggregated 13F filings for Q3 2024.